NCM
CCXI

Nantahala Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Nantahala Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,859
Closed -$280K – 127
2020
Q2 		$280K Buy
+4,859
New +$264K 0.01% 113
2019
Q1 		– Sell
-623,338
Closed -$6.8M – 105
2018
Q4 		$6.8M Sell
623,338
-20,000
-3% -$211K 0.21% 68
2018
Q3 		$8.13M Buy
643,338
+28,165
+5% +$339K 0.22% 62
2018
Q2 		$8.1M Buy
615,173
+14,685
+2% +$176K 0.33% 57
2018
Q1 		$8.17M Sell
600,488
-344,586
-36% -$3.56M 0.37% 50
2017
Q4 		$5.62M Buy
945,074
+267,295
+39% +$1.83M 0.25% 51
2017
Q3 		$5.03M Buy
677,779
+72,426
+12% +$602K 0.25% 46
2017
Q2 		$5.67M Hold
605,353
– – 0.45% 40
2017
Q1 		$4.41M Buy
605,353
+137,898
+29% +$993K 0.49% 38
2016
Q4 		$3.46M Buy
467,455
+1,015
+0.2% +$7.31K 0.36% 43
2016
Q3 		$2.82M Buy
466,440
+37,753
+9% +$178K 0.34% 45
2016
Q2 		$1.93M Buy
+428,687
New +$1.61M 0.21% 54

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Nantahala Capital Management's CCXI Position: Q3 2020 in Review

Nantahala Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q3 2020, closing a stake of 4,859 shares — an estimated $280K sold.

Nantahala Capital Management first reported a position in CCXI in Q2 2016 and held it in 12 quarters. The position peaked at $8.17M in Q1 2018. 204 funds tracked by Wall St. Rank hold CCXI as of Q3 2020.

  • Nantahala Capital Management reported no remaining ChemoCentryx, Inc. position as of Q3 2020 after selling out during the quarter.
  • Nantahala Capital Management sold 4,859 ChemoCentryx, Inc. shares in Q3 2020, an estimated $280K.
  • Nantahala Capital Management first reported a position in ChemoCentryx, Inc. in Q2 2016 and held it in 12 quarters.
  • Nantahala Capital Management's ChemoCentryx, Inc. position peaked at $8.17M in Q1 2018.
  • 204 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2020.

Based on Nantahala Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.